StockNews.com initiated coverage on shares of United-Guardian (NASDAQ:UG – Free Report) in a research note released on Friday. The firm issued a buy rating on the stock.
United-Guardian Price Performance
UG opened at $7.70 on Friday. The stock has a market capitalization of $35.37 million, a P/E ratio of 13.75 and a beta of 0.73. The company’s 50 day simple moving average is $8.09 and its 200-day simple moving average is $7.66. United-Guardian has a one year low of $5.79 and a one year high of $10.25.
United-Guardian (NASDAQ:UG – Get Free Report) last posted its quarterly earnings data on Friday, March 22nd. The company reported $0.16 earnings per share (EPS) for the quarter. The firm had revenue of $2.61 million for the quarter. United-Guardian had a return on equity of 24.26% and a net margin of 23.71%.
United-Guardian Announces Dividend
Institutional Investors Weigh In On United-Guardian
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN grew its holdings in shares of United-Guardian by 277.1% in the 2nd quarter. Wells Fargo & Company MN now owns 4,521 shares of the company’s stock valued at $37,000 after buying an additional 3,322 shares during the period. Citadel Advisors LLC raised its holdings in shares of United-Guardian by 55.4% during the second quarter. Citadel Advisors LLC now owns 15,694 shares of the company’s stock worth $134,000 after acquiring an additional 5,596 shares during the period. UBS Group AG lifted its position in United-Guardian by 7.3% in the 1st quarter. UBS Group AG now owns 17,657 shares of the company’s stock valued at $401,000 after acquiring an additional 1,207 shares in the last quarter. Northern Trust Corp acquired a new position in United-Guardian in the 4th quarter worth $151,000. Finally, Neuberger Berman Group LLC increased its holdings in United-Guardian by 66.6% during the 1st quarter. Neuberger Berman Group LLC now owns 93,340 shares of the company’s stock worth $2,123,000 after purchasing an additional 37,300 shares in the last quarter. Institutional investors own 23.16% of the company’s stock.
United-Guardian Company Profile
United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.
Recommended Stories
- Five stocks we like better than United-Guardian
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- The Charles Schwab Company Can Hit New Highs
- There Are Different Types of Stock To Invest In
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- The How and Why of Investing in Biotech Stocks
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.